Neogenesis Biotech Officially Joins INNOPAD TAIPEI

Collaborating to build an AI, precision medicine, and regenerative medicine startup ecosystem

On July 24, 2026, Neogenesis Biotech officially moved into INNOPAD TAIPEI, the flagship startup hub established by the Taipei City Government, becoming one of the first biotech startups to join the facility.

INNOPAD TAIPEI focuses on AI, smart healthcare, digital health, and high-tech innovation. It provides comprehensive startup incubation resources, connecting government agencies, medical institutions, academic and research units, industry partners, and international markets to help technically proficient startup teams accelerate their commercial development.

Neogenesis Biotech will showcase its latest Precise Cell Assessment,AI Cell Report and Companion Diagnostics technologies, looking forward to advancing the next generation of regenerative and precision medicine together with global medical institutions, pharmaceutical companies, biotech firms, and investment partners.

On-site demonstrations will include:

✔ AI Cell Report Smart Cell Analysis Platform

✔ Precision Cell Assessment

✔ Companion Diagnostics

✔ Flow Cytometry Multi-parameter Cell Analysis

✔ Cell Therapy Solutions

We look forward to seeing you at the Neogenesis Biotech booth

Date
July 24, 2026

Location
INNOPAD TAIPEI

We cordially invite healthcare institutions, biotech companies, pharmaceutical firms, investors, and partners to join us in exploring the latest advancements in AI and cell therapy.